🇺🇸 FDA
Patent

US 8206724

Method and compositions for vaccination comprising nucleic acid and/or polypeptide sequence of chlamydia

granted A61KA61K39/118A61P

Quick answer

US patent 8206724 (Method and compositions for vaccination comprising nucleic acid and/or polypeptide sequence of chlamydia) held by The Board of Regents of the University of Texas System expires Mon Jun 21 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jun 26 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 21 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K39/118, A61P, A61P37/02